Brain Metastasis in Patients with Small Cell Lung Cancer

References

• Couñago F, de la Pinta C, Gonzalo S, et al. GOECP/SEOR radiotherapy guidelines for small-cell lung cancer. World J Clin Oncol. 2021;12(3):115–143. doi:10.5306/wjco.v12.i3.115
   PubMed Web of Science ®Google Scholar
• Noronha V, Sekhar A, Patil VM, et al. Systemic therapy for limited stage small cell lung carcinoma. J Thorac Dis. 2020;12(10):6275–6290. doi:10.21037/jtd-2019-sclc-11
   PubMed Web of Science ®Google Scholar
• Hou R, Li H, Cao J, Song X, Zhang X, Wang W. Validation of a novel prognostic index: BMS-score for patients with brain metastases of small cell lung cancer. Ann Palliat Med. 2021;10(1):29–36. doi:10.21037/apm-20-1819
   PubMed Web of Science ®Google Scholar
• Ni W, Chen W, Lu Y. Emerging findings into molecular mechanism of brain metastasis. Cancer Med-Us. 2018;7(8):3820–3833. doi:10.1002/cam4.1667
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu XH, Wang Y, et al. A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases. Cancer Biol Ther. 2017;18(9):670–675. doi:10.1080/15384047.2017.1360450
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Canc Netw. 2021;19(3):254–266. doi:10.6004/jnccn.2021.0013
   PubMed Web of Science ®Google Scholar
• Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K. Treatment of brain metastases of non-small cell lung carcinoma. Int J Mol Sci. 2021;22(2):593. doi:10.3390/ijms22020593
   PubMed Web of Science ®Google Scholar
• Rusthoven CG, Yamamoto M, Bernhardt D, et al. Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study. JAMA Oncol. 2020;6(7):1028–1037. doi:10.1001/jamaoncol.2020.1271
   PubMed Web of Science ®Google Scholar
• Shi T, Song X, Liu Q, et al. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: a large population-based study. Cancer Med. 2019;8(13):6010–6020. doi:10.1002/cam4.2521
   PubMed Web of Science ®Google Scholar
• Song K, Shi X, Wang H, et al. Can a nomogram help to predict the overall and cancer-specific survival of patients with chondrosarcoma? Clin Orthop Relat Res. 2018;476(5):987–996. doi:10.1007/s11999.0000000000000152
   PubMed Web of Science ®Google Scholar
• Song K, Song J, Shi X, et al. Development and validation of nomograms predicting overall and cancer-specific survival of spinal chondrosarcoma patients. Spine. 2018;43(21):E1281–E1289. doi:10.1097/BRS.0000000000002688
   PubMed Web of Science ®Google Scholar
• Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640–649. doi:10.1056/NEJMoa1916623
   PubMed Web of Science ®Google Scholar
• Waqar SN, Waqar SH, Trinkaus K, et al. Brain metastases at presentation in patients with non-small cell lung cancer. Am J Clin Oncol. 2018;41(1):36–40. doi:10.1097/COC.0000000000000230
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang L, Zhao W, et al. Risk factors for brain metastasis in patients with small cell lung cancer without prophylactic cranial irradiation. Strahlentherapie Und Onkologie: Organ der Deutschen Rontgengesellschaft [Et Al]. 2018;194(12):1152–1162. doi:10.1007/s00066-018-1362-7
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Carico E. Role of HIF-1 in cancer progression: novel insights. a review. Curr Mol Med. 2018;18(6):343–351. doi:10.2174/1566524018666181109121849
   PubMed Web of Science ®Google Scholar
• Krug S, Teupe F, Michl P, Gress TM, Rinke A. Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome. BMC Cancer. 2019;19(1):362. doi:10.1186/s12885-019-5559-7
   PubMed Web of Science ®Google Scholar
• Fukui T, Itabashi M, Ishihara M, et al. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. BMC Cancer. 2016;16:197. doi:10.1186/s12885-016-2222-4
   PubMed Web of Science ®Google Scholar
• Yang J, Peng A, Wang B, et al. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis. Clin Exp Metastasis. 2019;36(5):457–466. doi:10.1007/s10585-019-09985-y
   PubMed Web of Science ®Google Scholar
• Steindl A, Schlieter F, Klikovits T, et al. Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort. J Neurooncol. 2019;145(1):85–95. doi:10.1007/s11060-019-03269-x
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Terzo F, Graziani ML, Ricci A, Bruno P, Mariotta S. Lung cancer requires multidisciplinary treatment to improve patient survival: a case report. Oncol Lett. 2017;14(3):3035–3038. doi:10.3892/ol.2017.6511
   PubMed Web of Science ®Google Scholar
• Edelman MJ. Prophylactic cranial irradiation for small-cell lung cancer: time for a reassessment. Am Soc Clin Oncol Educ Book. 2020;40:24–28. doi:10.1200/EDBK_281041
   PubMedGoogle Scholar
• Zeng H, Xie P, Meng X, et al. Risk factors for brain metastases after prophylactic cranial irradiation in small cell lung cancer. Sci Rep. 2017;7:42743. doi:10.1038/srep42743
   PubMed Web of Science ®Google Scholar
• Du X, Tian D, Liu L, et al. Surgery in patients with small cell lung cancer: a period propensity score matching analysis of the Seer database, 2010–2015. Oncol Lett. 2019;18(5):4865–4881. doi:10.3892/ol.2019.10792
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Yang TJ, Beal K, et al. Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). JAMA Oncol. 2017;3(6):827–831. doi:10.1001/jamaoncol.2016.3834
   PubMed Web of Science ®Google Scholar